Rock Springs Capital Management LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Rock Springs Capital Management LP disclosed 109 US equity positions worth $3.1bn in its Q3 2024 13F filing. The largest position was UNH at 5.6% of the reported book, followed by ISRG and ARGX.
What did Rock Springs Capital Management LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | UNH UNITEDHEALTH GROUP INC | Healthcare | 5.6% | $172.0m | 294,250 | – | |
| 2 | ISRG INTUITIVE SURGICAL INC | Healthcare | 4.3% | $132.6m | 270,000 | – | |
| 3 | ARGX ARGENX SE | Healthcare | 4.1% | $126.6m | 233,500 | – | |
| 4 | LLY ELI LILLY & CO | Healthcare | 4.1% | $125.8m | 142,000 | – | |
| 5 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.6% | $109.9m | 1,978,272 | – | |
| 6 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 3.5% | $108.2m | 939,000 | – | |
| 7 | EXK EXACT SCIENCES CORP | Basic Materials | 2.5% | $78.2m | 1,147,500 | – | |
| 8 | 2655787D BLUEPRINT MEDICINES CORP | 2.3% | $71.1m | 768,776 | – | ||
| 9 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 2.2% | $68.8m | 250,000 | – | |
| 10 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.1% | $65.5m | 4,684,476 | – | |
| 11 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 2.1% | $64.3m | 1,228,093 | – | |
| 12 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 2.0% | $61.6m | 1,580,488 | – | |
| 13 | FRPT FRESHPET INC | Consumer Defensive | 2.0% | $61.1m | 446,500 | – | |
| 14 | EVH EVOLENT HEALTH INC | Healthcare | 1.9% | $58.5m | 2,070,000 | – | |
| 15 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 1.8% | $55.8m | 263,062 | – | |
| 16 | PHR PHREESIA INC | Healthcare | 1.7% | $52.0m | 2,282,500 | – | |
| 17 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.7% | $51.8m | 1,316,477 | – | |
| 18 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 1.7% | $51.7m | 815,000 | – | |
| 19 | PEN PENUMBRA INC | Healthcare | 1.7% | $51.5m | 265,000 | – | |
| 20 | WST WEST PHARMACEUTICAL SVSC INC | Healthcare | 1.6% | $50.4m | 167,750 | – | |
| 21 | INSM INSMED INC | Healthcare | 1.6% | $49.9m | 683,344 | – | |
| 22 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 1.6% | $49.7m | 1,049,386 | – | |
| 23 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.6% | $48.5m | 325,000 | – | |
| 24 | HUM HUMANA INC | Healthcare | 1.5% | $46.9m | 148,000 | – | |
| 25 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.5% | $46.7m | 1,063,910 | – | |
| 26 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.5% | $45.8m | 1,009,945 | – | |
| 27 | MERUS N V | 1.5% | $44.6m | 892,549 | – | ||
| 28 | NUVALENT INC | 1.4% | $44.0m | 429,994 | – | ||
| 29 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 1.3% | $39.2m | 9,534,170 | – | |
| 30 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.3% | $38.5m | 460,000 | – | |
| 31 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.2% | $38.4m | 307,500 | – | |
| 32 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.2% | $38.1m | 576,900 | – | |
| 33 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.2% | $37.5m | 1,103,778 | – | |
| 34 | AGL AGILON HEALTH INC | Healthcare | 1.2% | $35.8m | 9,096,800 | – | |
| 35 | DXCM DEXCOM INC | Healthcare | 1.1% | $35.1m | 524,000 | – | |
| 36 | IMVT IMMUNOVANT INC | Healthcare | 1.1% | $34.8m | 1,221,309 | – | |
| 37 | ZLAB ZAI LAB LTD | Healthcare | 1.0% | $31.8m | 1,315,673 | – | |
| 38 | PODD INSULET CORP | Healthcare | 1.0% | $31.2m | 134,000 | – | |
| 39 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.0% | $31.1m | 699,389 | – | |
| 40 | IRTC IRHYTHM TECHNOLOGIES INC | Healthcare | 1.0% | $29.5m | 397,500 | – | |
| 41 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.9% | $29.1m | 114,500 | – | |
| 42 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.9% | $27.5m | 3,622,358 | – | |
| 43 | INSP INSPIRE MED SYS INC | Healthcare | 0.9% | $27.4m | 130,000 | – | |
| 44 | AKERO THERAPEUTICS INC | 0.9% | $26.8m | 933,399 | – | ||
| 45 | AZTA AZENTA INC | Healthcare | 0.8% | $25.8m | 532,500 | – | |
| 46 | LEGN LEGEND BIOTECH CORP | Healthcare | 0.8% | $24.8m | 508,932 | – | |
| 47 | WRBY WARBY PARKER INC | Healthcare | 0.8% | $23.5m | 1,439,050 | – | |
| 48 | SMMT SUMMIT THERAPEUTICS INC | Healthcare | 0.7% | $22.8m | 1,040,000 | – | |
| 49 | LFST LIFESTANCE HEALTH GROUP INC | Healthcare | 0.7% | $21.7m | 3,101,000 | – | |
| 50 | OSCR OSCAR HEALTH INC | Healthcare | 0.7% | $21.5m | 1,011,400 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.